Congrats to our undergraduate researchers, Anushka Silva, Leona Torosian, Christian Calderon, Anush Markaryan, Grace Hernandez, Davit Orujyan, Armani Oganyan, and Madona Masoud, on presenting their research posters at the 2018 Undergraduate research symposium.
This author has yet to write their bio.Meanwhile lets just say that we are proud Kai contributed a whooping 20 entries.
Entries by Kai
Ryan Davis, Kerrigan Blake, and Dustin Maurer present their 2017 Opportunity Award project results at the 2018 CCBS (Center for Complex Biological Systems) retreat.
Susan G. Komen Race for the Cure in LA with Dr. Josh Neman from USC
Lawson presents lab research program overview at ACS open house, where ACS volunteers and staff mingle, make blankets to donate to local cancer patients, and discuss cancer topics.
Together with Nick Navin’s lab at MD Anderson and Kai Kessenbrock’s lab at UCI, we have secured pilot funds from the Chan Zuckerberg Initiative to build a benchmark cell atlas of the human breast, using a series of single cell transcriptomic, epigenomic, and spatial genomic technologies.
The UCI Breast Cancer Program hosts a booth at the Susan G. Komen Race for the Cure in Orange County
Mechanoresponsive cell system (MRCS) can selectively identify and treat cancer metastases by targeting the specific biophysical cues in the tumor niche.
Congrats to Ryan on a new chapter, and Bon voyage to our spectacular lab manager Anh! We will miss you and best of luck in medical school.
Lawson and Kessenbrock labs race to raise funds for cancer research at UCI.
The Lawson lab is interested in understanding the cellular and molecular mechanisms underlying the metastatic spread of cancer cells to peripheral tissues. We take a systems-level approach, using cutting edge single-cell technologies to understand how the interplay between intracellular signals within the cancer cells, and extracellular stimuli from cells in the microenvironment influence the metastatic potential of individual cancer cells. We believe that new insights into the metastatic process will lead to new drugs to prevent and treat metastatic disease.
140 Sprague Hall
Chao Family Comprehensive Cancer Center
The University of California, at Irvine